Skip to content

RELMADA THERAPEUTICS, INC.: filings

Every RELMADA THERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 52 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 202630860001213900-26-086151
10-Q2026-05-12fiscal Q1 202629600001213900-26-055059
10-K2026-03-19fiscal FY 202529590001213900-26-031862
10-Q2025-11-13fiscal Q3 202528880001213900-25-109983
10-Q2025-08-07fiscal Q2 202529840001213900-25-073073
10-Q2025-05-12fiscal Q1 202528590001213900-25-042025
10-K2025-03-27fiscal FY 202428580001013762-25-003426
10-Q2024-11-07fiscal Q3 202429880001213900-24-095398
10-Q2024-08-07fiscal Q2 202427810001213900-24-066111
10-Q2024-05-08fiscal Q1 202428590001213900-24-040856
10-K2024-03-19fiscal FY 202329590001213900-24-024013
10-Q2023-11-08fiscal Q3 202328860001213900-23-084737
10-Q2023-08-08fiscal Q2 202327780001213900-23-064519
10-Q2023-05-11fiscal Q1 202328570001213900-23-038533
10-K2023-03-23fiscal FY 202230590001213900-23-022463
10-Q2022-11-10fiscal Q3 202228860001213900-22-071154
10-Q2022-08-11fiscal Q2 202227770001213900-22-046934
10-Q2022-05-05fiscal Q1 202228560001213900-22-024229
10-K2022-03-25fiscal FY 202130590001213900-22-015012
10-Q2021-11-12fiscal Q3 202130780001213900-21-058454
10-Q2021-08-10fiscal Q2 202129760001213900-21-041369
10-Q2021-05-12fiscal Q1 202128590001213900-21-025786
10-K2021-03-24fiscal FY 2020301040001213900-21-017556
10-Q2020-11-12fiscal Q3 202029810001213900-20-036542
10-Q2020-08-12fiscal Q2 202027730001213900-20-021649
10-Q2020-05-15fiscal Q1 202028590001213900-20-012693
10-Q2019-11-13fiscal Q1 202027570001213900-19-023219
10-K2019-09-24fiscal FY 201930600001213900-19-018787
10-Q2019-05-15fiscal Q3 201929800001213900-19-008633
10-Q2019-02-13fiscal Q2 201931800001213900-19-002391
10-Q2018-11-13fiscal Q1 201928570001213900-18-015476
10-K2018-09-28fiscal FY 201828580001213900-18-013238
10-Q2018-05-14fiscal Q3 201828700001213900-18-006121
10-Q2018-02-12fiscal Q2 201830780001213900-18-001597
10-Q2017-11-14fiscal Q1 201723490001213900-17-012121
10-K2017-09-28fiscal FY 201726530001213900-17-010097
10-Q2017-05-15fiscal Q3 201732860001213900-17-005185
10-Q2017-02-10fiscal Q2 201732860001213900-17-001191
10-Q2016-11-10fiscal Q1 201732660001213900-16-018211
10-K2016-09-09fiscal FY 201629590001213900-16-016664
10-Q2016-05-09fiscal Q3 201632850001213900-16-013088
10-Q2016-02-05fiscal Q2 201631860001213900-16-010641
10-Q2015-11-06fiscal Q1 201628580001213900-15-008265
10-K2015-09-11fiscal FY 201525670001213900-15-006928
10-Q2015-05-15fiscal Q3 201527750001213900-15-003882
10-Q2015-02-13fiscal Q2 201527740001213900-15-001037
10-Q2014-11-07fiscal Q1 201524490001213900-14-007845
10-Q2014-04-15fiscal Q2 201421570001255294-14-000328
10-Q2014-01-13fiscal Q1 201420450001504167-14-000017
10-K2013-12-16fiscal FY 201320510001255294-13-001000
10-Q2013-07-12fiscal Q3 201319560001255294-13-000523
10-Q2013-05-03fiscal Q2 201316510001255294-13-000318

Inspect the source

Entity
RELMADA THERAPEUTICS, INC. / CIK 0001553643
Captured
2026-09-19T11:18:56.464Z
SEC response SHA-256
34acb6579adb694402af1f940d83014f7841c8cf763b03e27ee64d386466bb53

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001553643.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))